Herbert Sindermann
5Patents
1h-index
6Co-inventors
40Inventor score
Filing activity: Jul 30, 2003 → May 30, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10288629B1 | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition | Physics | 1 | Active |
| US8383605B2 | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals | Human Necessities | 0 | Active |
| US8389497B2 | Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals | Human Necessities | 0 | Expired |
| US8507710B2 | Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals | Human Necessities | 0 | Active |
| US8551977B2 | Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.